RESP — Respiratorius AB (publ) Share Price
Last trade - 00:00- SEK119.85m
- SEK119.85m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.52 | ||
| Price to Tang. Book | 128.73 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -29.53% | ||
| Return on Equity | -25.76% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | 0.13 | n/a | 33 | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Respiratorius AB (publ) is a Sweden-based biotechnology and pharmaceutical company. It develops candidate drugs for treatment of cancer, Chronic Obstructive Pulmonary Disease (COPD) and asthma. The project portfolio also includes development of a biomarker for cardiovascular positron-emission tomography (PET)-imaging. The oncology drug project VAL-001 aims for first-line treatment of Diffuse Large B-Cell Lymphoma (DLBCL). In the COPD and asthma projects, the Company develops two classes of drug substances, such as RESP-1000 and RESP-2000 series for bronchodilating effect on small airways. The Company’s primary markets are the United States and South Africa.
Directors
- Christer Fahraeus CHM (56)
- Johan Drott CEO
- Carl-Magnus Andersson OTH
- Jorgen Gustafsson OTH
- Martin Johansson OTH
- Kristina Drott DRC (42)
- Sarah Fredriksson DRC (53)
- Ingemar Kihlstrom DRC (67)
- Olov Sterner DRC (67)
- Anna Torner DRC
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 30th, 1998
- Public Since
- July 5th, 2012
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 292,316,071
- Address
- Medicon Village, Scheelevagen 2, LUND, 223 81
- Web
- https://www.respiratorius.com/
- Phone
- +46 709224140
- Auditors
- Crowe Osborne AB
Upcoming Events for RESP
Similar to RESP
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Arcede Pharma AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
As of Today at 19:18 UTC, shares in Respiratorius AB (publ) are trading at SEK0.41. This share price information is delayed by 15 minutes.
Shares in Respiratorius AB (publ) last closed at SEK0.41 and the price had moved by +7.33% over the past 365 days. In terms of relative price strength the Respiratorius AB (publ) share price has underperformed the FTSE Global All Cap Index by -1% over the past year.
There is no consensus recommendation for this security.
Respiratorius AB (publ) does not currently pay a dividend.
Respiratorius AB (publ) does not currently pay a dividend.
Respiratorius AB (publ) does not currently pay a dividend.
To buy shares in Respiratorius AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.41, shares in Respiratorius AB (publ) had a market capitalisation of SEK119.85m.
Here are the trading details for Respiratorius AB (publ):
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: RESP
Based on an overall assessment of its quality, value and momentum Respiratorius AB (publ) is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Respiratorius AB (publ) is SEK0.40. That is 2.44% below the last closing price of SEK0.41.
Analysts covering Respiratorius AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Respiratorius AB (publ). Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +61.34%.
As of the last closing price of SEK0.41, shares in Respiratorius AB (publ) were trading +71.13% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Respiratorius AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Respiratorius AB (publ)'s management team is headed by:
- Christer Fahraeus - CHM
- Johan Drott - CEO
- Carl-Magnus Andersson - OTH
- Jorgen Gustafsson - OTH
- Martin Johansson - OTH
- Kristina Drott - DRC
- Sarah Fredriksson - DRC
- Ingemar Kihlstrom - DRC
- Olov Sterner - DRC
- Anna Torner - DRC